Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
ENSC holding history
Ensysce Biosciences, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENSC overviewAll 13F holders of ENSCFull Q2 2026 holdings
- Shares (Q2 2026)
- 86,193
- Value
- $25.0K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 86,193 | $25.0K | <0.1% | +28,830+50.3% | Added | Holders |
| Q1 2026 | 57,363 | $30.9K | <0.1% | +57,363 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −14,518−100.0% | Sold out | Holders |
| Q3 2025 | 14,518 | $34.4K | <0.1% | +14,518 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −23,605−100.0% | Sold out | Holders |
| Q3 2024 | 23,605 | $5.67K | <0.1% | −62,734−72.7% | Reduced | Holders |
| Q2 2024 | 86,339 | $43.7K | <0.1% | +86,339 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −19,113−100.0% | Sold out | Holders |
| Q3 2023 | 19,113 | $26.2K | <0.1% | +19,113 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −42,277−100.0% | Sold out | Holders |
| Q4 2022 | 42,277 | $31.7K | <0.1% | +42,277 | New | Holders |